Drug Name: Skyclarys
Indications: To treat Friedrich’s ataxia.
Active Ingredient: Omaveloxolone
Company: Reata Pharmaceuticals Holdings
Approval Date: 2/28/2023
More Details: https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/216718Orig1s000lbl.pdf